Suicide gene therapy involves the selective introduction of cellular suicide-inducing transgenes in cancer cells. The therapy involves silencing the expression of genes, intracellular antibodies, vital pathways, and transgenic expression of caspases and DNase. It can be administered through multiple-delivery routes, such as viruses, non-viral vectors, liposomes, nanoparticles, and stem cells. ##Disclaimer## The content provided on Docplexus is intended for educational purposes only.
While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas or service, including the content from our industry partners. We do not associate with the views of any individual, community, organization, industry…
